Skip to Content

Annual Reports & Financials

Reimbursement & Policy

Public Comments

Collaborative Studies

BLOODPAC Portal

BLOODPAC 10 Summit

Educational Seminars

Upcoming Events

BLOODPAC Publications

Frameworks & Standards

Member Publications

BLOODPAC Dictionary

BLOODPAC Governance

Job Opportunities

Annual Reports & Financials

Reimbursement & Policy

Public Comments

Collaborative Studies

BLOODPAC Portal

BLOODPAC 10 Summit

Educational Seminars

Upcoming Events

BLOODPAC Publications

Frameworks & Standards

Member Publications

BLOODPAC Dictionary

BLOODPAC Governance

Job Opportunities

Annual Reports & Financials

Folder: Approach

Reimbursement & Policy

Public Comments

Collaborative Studies

BLOODPAC Portal

BLOODPAC 10 Summit

Educational Seminars

Upcoming Events

BLOODPAC Publications

Frameworks & Standards

Member Publications

Folder: Resources

BLOODPAC Dictionary

BLOODPAC Governance

Job Opportunities

BLOODPAC Quarterly Newsletter: 2025 Q3

Oct 5

Written by Cheyenne Jankiewicz

Cheyenne Jankiewicz

Performance with Metrics in Early Detection

BLOODPAC Quarterly Newsletter: 2025 Q2

ABOUT

BLOODPAC is a South Carolina based 501 (c)(3) not-for-profit corporation. Our mission is to accelerate the development, validation, and accessibility of liquid biopsy assays to improve outcomes for patients with cancer. To do so, we lead a pre-competitive collaborative infrastructure that enables the sharing of information and building of consensus among stakeholders in industry, academia, regulatory bodies, payers, and government agencies.